Abstract
predialysis patients had not been assessed. In this tration decreased from 21.2±6.4 to 14.2±4.6 mmol/l (P<0.001) between To and T3 (a 33% decrease) and paper, we report the results observed in 78 predialysis patients who received long-term, i.e. for at to 12.8±3.7 mmol/l (P<0.001) at Tf (a 40% decrease), whereas mean plasma creatinine value rose from least 1 year (and up to 6 years), moderate folic acid supplementation together with pyridoxine and vitamin 268±129 to 399±234 mmol/l and creatinine clearance declined from 28.4±12.7 to 21.2±12.6 ml/min/1.73m2 B12 supplementation.
from To to Tf. Plasma homocysteine level was in excess of 14.1 mmol in 95% of patients at baseline, and in
Patients and methods
only 37% at 3 months and 31% at Tf (P<0.01). The per cent decline in homocysteine level between To and Patients Tf did not differ between the 11 patients who received EPO therapy with 5 mg/day folic acid (−37%) and in The study was prospective. All 78 patients (49 males, 29 the 67 patients who received 2.15 mg/day folic acid females, all Caucasian) were ambulatory, in good general (−40%).
and nutritional condition and were managed as outpatients.
Plasma vitamin B12 level at baseline was Their ages ranged from 28 to 87 years (mean±SD: 60.6±13.7 <150 pmol/l (the lower limit of normal values) in 28% years). No patient was on dialysis or had been transplanted. of patients and in the lower quartile of normal values Serum creatinine (Scr) ranged from 131 to 638 mmol/l.
(150-300 pmol/l ) in 42% of patients. Plasma folate Primary nephropathy was chronic glomerulonephritis in 14, level was subnormal in no patient, but was in the lower chronic interstitial nephritis in 21, polycystic kidney disease in 13, angionephrosclerosis in 23, diabetic nephropathy in quartile of normal values (7-14nmol/l ) in 47% of four and other or unknown in four. Body mass index (BMI ) patients. Mean plasma vitamin B12 and folate concenwas Á20 kg/m2 and serum albumin was >35 g/l in all trations rose significantly from To to T3 and remained patients at the start of follow-up.
at the same level until Tf. In particular, plasma folate Of the 78 patients, 67 received oral supplementation with concentration ranged between 34 nmol/l (the upper folic acid (5 mg three times per week, or 2.15 mg/ day as a limit in healthy subjects) and 60 nmol/l in all mean) together with pyridoxine (250 mg twice per week) and supplemented patients. No side-effect which could be vitamin B12 (1 mg twice per week). Eleven patients who attributed to folic acid supplementation was observed.
required recombinant erythropoietin therapy received 5 mg/day folic acid with the same vitamin B6 and B12 supplementation.
Discussion
Plasma total homocysteine concentration was determined in the fasting state together with plasma vitamin B12 and folate concentration at baseline ( To), after three months In view of the growing prevalence of hyperhomocystei-(T3) and at the end of follow-up ( Tf ), i.e. at start of naemia with progression of chronic renal failure, and maintenance dialysis or by December 1997. All patients of its deleterious atherogenic effects, attempts to reduce underwent regular clinical surveillance and serial serum homocysteine levels from the earliest stage of CRF creatinine determinations. Follow-up duration ranged from would be strongly indicated. This large cohort study is the first to provide evidence that long-term moderate folic acid supplementation Methods (2.15 mg/day) allows a substantial (40% as a mean) and sustained (up to 6 years) reduction in plasma total
Plasma total (free+protein bound ) homocysteine was meashomocysteine level in predialysis CRF patients. It is ured using the rapid-enzymatic method of Refsum et al. [19] of note that throughout the entire follow-up period as modified by Chadefaux et al. [20] . The normal value for plasma total homocysteine remained at the level to total homocysteine concentration in 45 healthy controls was 8.2±2.2 mmol/l (upper limit: 14.1 mmol/l ). Plasma vitamin which it had decreased after 3 months, although renal B12 and folate levels were determined by radioimmunoassay. function declined markedly in the meantime. Previous The normal range for plasma folate concentration was studies in predialysis patients are few and have been 7-34 nmol/l and 150-750 pmol/l for vitamin B12. Creatinine only short-term. Wilcken et al.
[12] reported a significclearances were assessed using the Cockcroft and Gault ant decline in plasma homocysteine in 21 predialysis formula [21] which has been shown to apply to subjects with uraemic patients following a 2-week course with impaired renal function [22] .
5 mg/day folic acid. We observed a 40% decrease in 
Results
this preliminary trial. Subnormal or low-normal plasma levels of vitamin B12, folic acid and/or pyridoxine are associated with Mean plasma levels of total homocysteine and creatinine at baseline (To), after 3 months (T3) and at the an elevated plasma homocysteine level in the general population, particularly in elderly subjects [23] . Some end of follow-up (Tf ), together with plasma vitamin B12 and folate levels, are given in Table 1 for the degree of folic acid and/or vitamin B6 deficiency is known to be present in ESRD patients and may whole series. Mean plasma total homocysteine concen- 
